|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52618698
???header.onlineuser??? :
790
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"im"???jsp.browse.items-by-author.description???
Showing items 11-12 of 12 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-05 |
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
|
Hurvitz;S, A.;Kim;S, -B.;Chung;W, -P.;Im;S, -A.;Park;Y, H.;Hegg;R;Kim;M, -H.;Tseng;L, -M.;Petry;V;Chung;C, -F.;Iwata;H;Hamilton;E;Curigliano;G;Xu;B;Egorov;A;Liu;Y;Cathcart;J;Bako;E;Tecson;K;Verma;S;Cortes;J |
| 國立成功大學 |
2024 |
Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
|
Xu;B;Wang;S;Yan;M;Sohn;J;Li;W;Tang;J;Wang;X;Wang;Y;Im;S, -A.;Jiang;D;Valdez;T;Dasgupta;A;Zhang;Y;Yan;Y;Komatsubara;K, M.;Chung;W, -P.;Ma;F;Dai;M, -S. |
Showing items 11-12 of 12 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
